Safety of rapid rituximab infusion in adult cancer patients: a systematic review.
about
Rituximab-related reversible hepatocellular damage.Rapid rituximab infusion is safe in paediatric and young adult patients with non-malignant indications.A Retrospective Study on Infusion-Related Reactions to Rituximab in a Heterogeneous Pediatric Population.Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders.
P2860
Safety of rapid rituximab infusion in adult cancer patients: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of rapid rituximab infusion in adult cancer patients: a systematic review.
@en
Safety of rapid rituximab infusion in adult cancer patients: a systematic review.
@nl
type
label
Safety of rapid rituximab infusion in adult cancer patients: a systematic review.
@en
Safety of rapid rituximab infusion in adult cancer patients: a systematic review.
@nl
prefLabel
Safety of rapid rituximab infusion in adult cancer patients: a systematic review.
@en
Safety of rapid rituximab infusion in adult cancer patients: a systematic review.
@nl
P2860
P1476
Safety of rapid rituximab infusion in adult cancer patients: a systematic review
@en
P2093
Alan Pearson
Dora S P Lang
P2860
P304
P356
10.1111/J.1440-172X.2011.01950.X
P577
2011-08-01T00:00:00Z